Aldeyra Therapeutics to Participate in Upcoming Investor Conferences
August 28 2019 - 8:30AM
Business Wire
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a
biotechnology company devoted to developing and commercializing
next-generation medicines to improve the lives of patients with
immune-mediated diseases, today announced that Todd C. Brady, M.D.,
Ph.D., President and CEO of Aldeyra, will participate in the
following investor conferences in September:
- Citi’s 14th Annual Biotech Conference Four Seasons Hotel
Boston, Mass. Thursday, September 5, 2019
- BioCentury 26th Annual NewsMakers in the Biotech
Industry Millennium Times Square New York New York, N.Y.
Friday, September 6, 2019
- 3rd Annual Janney Healthcare Conference The Union League
Club New York, N.Y. Monday, September 9, 2019 Presentation
time: 11:50 a.m. ET
The Janney presentation will be webcast live and archived on the
“Investors” section of the Aldeyra website,
http://ir.aldeyra.com/.
About Aldeyra Therapeutics Aldeyra Therapeutics is a
biotechnology company devoted to developing and commercializing
next-generation medicines to improve the lives of patients with
immune-mediated diseases. Aldeyra's lead investigational drug
product candidates are first-in-class potential treatments in
development for dry eye disease, allergic conjunctivitis,
proliferative vitreoretinopathy, and Sj�gren-Larsson Syndrome. The
company is also developing other product candidates for retinal and
systemic inflammatory diseases.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190828005400/en/
Corporate Contact: David McMullin Aldeyra Therapeutics,
Inc. Tel: 781-761-4904 ext. 218 dmcmullin@aldeyra.com
Investor & Media Contact: Scott Solomon Sharon
Merrill Associates, Inc. Tel: 617-542-5300
ALDX@investorrelations.com
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart
From Apr 2023 to Apr 2024